BOSTON (AP) 鈥� BOSTON (AP) 鈥� Monte Rosa Therapeutics Inc. (GLUE) on Thursday reported a loss of $43.4 million in its second quarter.
The Boston-based company said it had a loss of 43 cents per share.
The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 25 cents per share.
The biopharmaceutical company posted revenue of $9 million in the period, also missing Street forecasts. Three analysts surveyed by Zacks expected $25.7 million.
_____
This story was generated by (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a at https://www.zacks.com/ap/GLUE
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
